ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)
for
Spinal Muscular Atrophy
Location: New York NY
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 2 - 70+
Code: NCT07448610
Recruiting
New
HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor
for
Solid Tumors, Adult
Location: Tamarac FL, Plantation FL, Atlanta GA
Sponsor: Hutchmed
Sex: All
Age: 18+
Code: NCT07396584
Phase1, Phase2, Recruiting
New
Parent-Adolescent Relationships, Emotional Regulation, and HRV in Adolescents With Depression
for
Emotional Dysregulation, HRV, Adolescent, Family Relationship,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 12 - 18
Code: NCT07430774
Recruiting
New
Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma
for
Phase II, Sacituzumab, Tirumotecan,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07438626
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Location: Jersey City NJ, Marlton NJ, Coral Gables FL, Weston FL,
Sponsor: ECRI bv
Sex: All
Age: 18+
Code: NCT06625801
Recruiting
New
Singula Phase 0.1 Primary Care Pilot
for
Depression - Major Depressive Disorder, Anxiety
Location: Mount Kisco NY
Sponsor: Singula Health, Inc.
Sex: All
Age: 18+
Code: NCT07834684
Recruiting
New
Adaptive Versus Non-adaptive Radiotherapy and 2 Bladder Filling Instructions for Patients With Intermediate or High Risk Localized Prostate Cancer (ARP)
for
Prostate Cancer
Location: Vancouver
Sponsor: Scott Tyldesley
Sex: Male
Age: 18+
Code: NCT06678126
Phase2, Recruiting
Active & ResponsiveNew
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
for
Colorectal Cancer
Location: Toms River NJ, Edison NJ, East Brunswick NJ, Monroe NJ,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT07750158
Phase3, Recruiting
New
Use of VR for Diagnostic Hysteroscopy
for
Hysteroscopy, Anxiety, Pain
Location: Montreal
Sponsor: St. Justine's Hospital
Sex: Female
Age: 18+
Code: NCT07173231
Recruiting
New
Co-Adaptation of an Digital Pain Management Program for Canadian Veterans
for
Chronic Pain, Veterans
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18 - 70+
Code: NCT07818980
Recruiting
Active & ResponsiveNew
Cyclic vs. Constant Estradiol: Regimens' Effects on Brain Health
for
Menopause, Healthy Adult, Brain, Postmenopausal
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: Female
Age: 38 - 60
Code: NCT07831499
Recruiting
New
Randomized Evaluation of Natural Extract for Menopausal Wellness (RENEW)
for
Menopause, Hot Flashes
Location: New Port Richey FL
Sponsor: India Glycols Ltd
Sex: Female
Age: 45 - 60
Code: NCT07834463
Recruiting
New
At-Home Paracentesis for Cancer-Related Malignant Ascites (Paracentesis)
for
Malignant Ascites
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 18+
Code: NCT07490626
Recruiting
New
A Post Authorization Registry Study of Participants Treated With LEQEMBI
for
Alzheimers Disease
Location: Toronto
Sponsor: Eisai Limited
Sex: All
Age: 0+
Code: NCT07762092
Recruiting
New
A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
for
Diabetes Mellitus, Type 1, Overweight, Obesity
Location: Miami FL
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT07803744
Phase1, Recruiting
Active & ResponsiveNew
The Gut - PRO Study
for
Alzheimer Disease
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 60+
Code: NCT07413744
Phase1, Recruiting
Active & ResponsiveNew
The Role of Visual Attention and Environmental Complexity in Real-world Mobility for People With Lower Limb Amputation
for
Lower Limb Amputation
Location: Richmond VA
Sponsor: Virginia Commonwealth University
Sex: All
Age: 18+
Code: NCT07831707
Recruiting
New
Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy